Hengrui Pharmaceutical was founded in 1970 and listed on the Shanghai Stock Exchange in 2000. It is an innovative international pharmaceutical enterprise that focuses on the research and development, production, and promotion of high-quality drugs. It focuses on the research and development of new drugs in fields such as anti-tumor, metabolic diseases, autoimmune diseases, respiratory diseases, and neurological diseases. It is one of the most innovative pharmaceutical leading enterprises in China. For more than 50 years, Hengrui Pharmaceutical has always adhered to the original intention of serving patients, worked hard to protect the healthy life and quality of life of patients, overcome difficulties, and promote the high-quality development of the pharmaceutical industry. Hengrui Pharmaceuticals has been on the top 50 global pharmaceutical companies list published by the American Journal of Pharmaceutical Managers for five consecutive years; In the "Top 25 Global Pharmaceutical Enterprise R&D Pipeline Scale" list selected by the global pharmaceutical think tank information platform Informa Pharma Intelligence, Hengrui Pharmaceutical ranks 13th, setting a new high for Chinese pharmaceutical companies on this list; The China Pharmaceutical Industry Information Center has released the "Best Industrial Enterprise in China's Pharmaceutical R&D Product Line" over the years, and Hengrui Pharmaceutical has topped the list 11 times.
Odor components | Odor inlet indicators | Odor discharge indicators | Exhaust pipe height |
H2S | ≤100mg/m3 | ≤0.6kg/h | 15m |
NH3 | ≤40mg/m3 | ≤0.6kg/h | |
C2H6S | ≤50mg/m3 | ≤0.6kg/h | |
Odour | ≤3000 | ≤800 |